b 071 300
Pill imprint b 071 300 has been identified as Isoniazid 300 mg.
Isoniazid is used in the treatment of tuberculosis, latent; tuberculosis, active; tuberculosis, prophylaxis; mycobacterium kansasii and belongs to the drug class nicotinic acid derivatives. Risk cannot be ruled out during pregnancy.
Isoniazid 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Isoniazid Images
- Imprint:
-
b
071 300 - Strength:
- 300 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
microcrystalline cellulose
corn starch
magnesium silicate
- Drug Class:
- Nicotinic acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0071
More Isoniazid resources
- Isoniazid (Wolters Kluwer)
- Isoniazid Syrup (Wolters Kluwer)
- Isoniazid Tablets (Wolters Kluwer)
- isoniazid (Cerner Multum)
- Pms-Isoniazid (Micromedex) - Includes Dosage Information
- isoniazid Oral, Intramuscular (Micromedex) - Includes Dosage Information
- Isoniazid (AHFS DI)
- Isoniazid Injection (FDA)
- Isoniazid Solution (FDA)
- Isoniazid Syrup (FDA)
- Isoniazid Tablets (FDA)
- Isoniazid (Isonicotinic Acid Hydrazide; INH) (Wolters Kluwer)


